Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Roundup
Read our September roundup to find out more about new key developments in the Next-Generation Therapeutics Space.
October 14, 2022

Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Roundup
Read our September roundup to find out more about new key developments in the Next-Generation Therapeutics Space.
October 14, 2022
Next-Generation Therapeutics
.png)
DeciBio Q&A
Clinical Diagnostics
DxBooks Insights: One reference lab's approach to the monkeypox outbreak
We sat down with a lab director to learn more about how a large reference lab approached monkeypox testing.
October 10, 2022
.png)
DeciBio Q&A
Clinical Diagnostics
DxBooks Insights: One reference lab's approach to the monkeypox outbreak
We sat down with a lab director to learn more about how a large reference lab approached monkeypox testing.
October 10, 2022
Clinical Diagnostics
Infectious Diseases
Medical Devices

Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Roundup
Liquid Biopsy (LBx) continued to develop through September, featuring ample product launches and clinical trial publications spurred on by ESMO conferences.
October 6, 2022

Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Roundup
Liquid Biopsy (LBx) continued to develop through September, featuring ample product launches and clinical trial publications spurred on by ESMO conferences.
October 6, 2022
Liquid Biopsy
.png)
Newsletter Update
Pharma & Biotech
Digital Health | Q3 Update
While the economic slump looks as though it may continue through the final quarter of 2022, we will continue to stay abreast of emerging developments in digital health.
October 5, 2022
.png)
Newsletter Update
Pharma & Biotech
Digital Health | Q3 Update
While the economic slump looks as though it may continue through the final quarter of 2022, we will continue to stay abreast of emerging developments in digital health.
October 5, 2022
Health Technology Market
Medical Devices
Digital Health

Blog Article
Pharma & Biotech
IGF 2022: DeciBio Highlights – Illumina delivers
Read about our take on Illumina's new line of product launched at its inaugural Illumina Genomics Forum (IGF) last week.
October 3, 2022

Blog Article
Pharma & Biotech
IGF 2022: DeciBio Highlights – Illumina delivers
Read about our take on Illumina's new line of product launched at its inaugural Illumina Genomics Forum (IGF) last week.
October 3, 2022
Next-Generation Therapeutics

DeciBio Q&A
Clinical Diagnostics
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022

DeciBio Q&A
Clinical Diagnostics
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Digital Pathology

Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved